Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT

Risk Summary

Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device.

CVEs (2)

Remediations

• Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https://www.apollopharmacy.in/contact-us.
• CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https://www.cisa.gov/news-events/news/understanding-bluetooth-technology.

Affected Vendors

Affected Products (1)

Affected Sectors

Healthcare and Public Health